🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Track obesity and metabolic disease catalysts with approval-probability scores and free alerts.

Obesity & Metabolic Biotech Pipeline: Weight Loss and Diabetes Drugs

Every obesity and metabolic disease program BioRadar tracks across 95 public biotech companies — drug candidates, trial phases and upcoming FDA decisions. Updated automatically.

Pipelines by area: OncologyInfectious DiseaseNeurology / CNSObesity / Metabolic

BioRadar is tracking 386 obesity and metabolic disease drug programs across 95 public companies. The most active companies by program count are MNKD, ORMP, LLY, LXRX, NVO.

386Drug programs
95Companies
114In Phase 3
0Upcoming FDA dates

Companies with obesity and metabolic disease programs

Phase 3 obesity & metabolic programs (114)

TickerDrugIndication
ABEO MSI-78 Diabetic Foot Ulcers
ABEO ofloxacin Diabetic Foot Ulcers
ABT Sotagliflozin Low Dose Type 1 Diabetes (T1D)
ABT Sotagliflozin High Dose Type 1 Diabetes (T1D)
ALKS Human Insulin Inhalation Powder Diabetes Mellitus
ALKS injected insulin Diabetes Mellitus
ALKS Injectable insulin Diabetes Mellitus, Type 2
ALKS Insulin Glargine Diabetes Mellitus, Type 2
ALT Pemvidutide Metabolic Dysfunction-Associated Steatohepatitis (
ALVO AVT29 (proposed aflibercept HD biosimila Diabetic Macular Edema
ALVO Eylea HD (aflibercept HD) Diabetic Macular Edema
AMGN Semaglutide Diabetes Mellitus, Type 2
ARWR zodasiran Injection Homozygous Familial Hypercholesterolemia
ARWR Zodasiran Homozygous Familial Hypercholesterolemia
AZN AZD0780 Dyslipidaemia
AZN Rosuvastatin Dose 1 Dyslipidaemia
AZN Rosuvastatin dose 2 Dyslipidaemia
COLL Empagliflozin 20 mg Metabolic Syndrome
COLL Empagliflozin 10 mg Metabolic Syndrome
EOCN Aramchol free acid Nonalcoholic Steatohepatitis (NASH)
FDMT EYELEA ® (aflibercept) Injection 2 mg (0 Diabetic Macular Edema (DME)
FDMT 4D-150 IVT (3x10^10 vg) Diabetic Macular Edema (DME)
GPCR Aleniglipron Obesity
IVA IVA337 NASH - Nonalcoholic Steatohepatitis
KLRA Ribupatide Obesity With Diabetes
KLRA Semaglutide Obesity
KOD Tabirafusp tedromer Diabetic Macular Edema (DME)
KOD Aflibercept (2.0 mg) Diabetic Macular Edema (DME)
KOD Tarcocimab Diabetic Retinopathy
KOD KSI-301 Non-proliferative Diabetic Retinopathy
LLY Retatrutide Obesity
LLY Eloralintide Obesity
LLY eloralintide and tirzepatide Obesity
LXRX Sotagliflozin Diabetic Nephropathies
LXRX Sotagliflozin Low Dose Type 1 Diabetes (T1D)
LXRX Sotagliflozin High Dose Type 1 Diabetes (T1D)
LXRX Sotagliflozin (SAR439954) Type 2 Diabetes Mellitus
LXRX Metformin Type 2 Diabetes Mellitus
LXRX Sulfonylurea Type 2 Diabetes Mellitus
LXRX Oral Antidiabetes Drugs (OADs) Type 2 Diabetes Mellitus

Phase 2 obesity & metabolic programs (168)

TickerDrugIndication
ABBV Standard of Care Diabetic Retinopathy, DR
ABBV Aflibercept Diabetic Retinopathy, DR
AKBA IW-1973 Type 2 Diabetes Mellitus With Diabetic Nephropathy
ALGS ALG-055009 NASH
ALNY ALN-2232 Obesity
ALNY Tirzepatide Obesity
ALNY ALN-4324 Type 2 Diabetes Mellitus (T2DM)
ALNY ALN-KHK Type 2 Diabetes Mellitus (T2DM)
ALT ALT-801 Obesity/Overweight
APMD AD981 Obesity Hypoventilation Syndrome (OHS)
ARWR ARO-ANG 3 Injection Homozygous Familial Hypercholesterolemia
ARWR ARO-APOC3 Dyslipidemias
ARWR ARO-ANG3 Mixed Dyslipidemia
ARWR ARO-DIMERPA Hyperlipidemia; Mixed
ARWR ARO-ALK7 Obesity
ARWR Tirzepatide Obesity
ARWR ARO-INHBE Obesity
BIOA Oral BGE-102 Obesity and Cardiovascular Risk
BIOA Anti-VEGF Diabetic Macular Edema (DME)
BIOA Oral Azelaprag (BGE-105) Obesity
BIOA Tirzepatide Obesity
BMEA BMF-219 Type 2 Diabetes Mellitus
BMEA icovamenib 100mg Type 2 Diabetes
BMEA icovamenib 100 mg Type 2 Diabetes
CELZ CELZ-201 Administration Type 1 Diabetes
CELZ C-peptide Diabetes Mellitus, Type 1
CORT Miricorilant Antipsychotic-induced Weight Gain (AIWG)
CORT Miricorilant (Cohort A) Nonalcoholic Steatohepatitis (NASH)
CORT Miricorilant (Cohort B) Nonalcoholic Steatohepatitis (NASH)
CORT Miricorlilant Antipsychotic-induced Weight Gain (AIWG)
CPIX Atorvastatin injection Hypercholesterolemia
EDIT Drug: EDIT-401 Heterozygous Familial Hypercholesterolemia (HeFH)
ELDN Islet transplantation with Tegoprubart ( Type 1 Diabetes Mellitus
ELDN Isolated cadaveric islet cells Brittle Type 1 Diabetes Mellitus
ELDN AT-1501 IV Infusion Brittle Type 1 Diabetes Mellitus
FBLG SoC + High dose CYWC628 Diabetic Foot Ulcer (DFU)
FBLG SoC + Low dose CYWC628 Diabetic Foot Ulcer (DFU)
GPCR ACCG-2671 Obesity
GPCR GSBR-1290 Overweight or Obesity
GRFS IGIV-C Diabetes Complications

Phase 1 obesity & metabolic programs (67)

TickerDrugIndication
ABUS PRO-040201 Hypercholesterolemia
ALNY ALN-6222 Obesity
ALT Warfarin NASH - Nonalcoholic Steatohepatitis
ALT Atorvastatin NASH - Nonalcoholic Steatohepatitis
ALT Ethinylestradiol and Levonorgestrel NASH - Nonalcoholic Steatohepatitis
ALT Digoxin NASH - Nonalcoholic Steatohepatitis
ALT Metformin NASH - Nonalcoholic Steatohepatitis
AMRN Icosapent Ethyl 1000 MG [Vascepa] Lipid Disorder
BMEA BMF-650 Obesity
CMMB CM-101 Nonalcoholic Steatohepatitis (NASH)
CORT Miricorilant 100 mg Nonalcoholic Steatohepatitis (NASH)
CORT Miricorilant 10 mg Nonalcoholic Steatohepatitis (NASH)
CORT Miricorilant 50 mg Nonalcoholic Steatohepatitis (NASH)
CORT Miricorilant 150 mg Nonalcoholic Steatohepatitis (NASH)
CORT Fluvoxamine Antipsychotic Induced Weight Gain
CORT Olanzapine Antipsychotic-induced Weight Gain
CORT CORT118335 Antipsychotic-induced Weight Gain
ENTA EDP-297 NASH - Nonalcoholic Steatohepatitis With Liver Fib
ENTA Oral Contraceptive NASH - Nonalcoholic Steatohepatitis
ENTA EDP-305 NASH - Nonalcoholic Steatohepatitis
ENTA EDP 305 NASH - Nonalcoholic Steatohepatitis
ENTA intraconazole NASH - Nonalcoholic Steatohepatitis
FATE ProHema-CB Transplant Metabolic Disorders
IBIO IBIO-600 Overweight , Obesity
IBIO IBIO-610 Obesity & Overweight
ICLR Petrelintide Obesity & Overweight
IMCR IMC-S118AI Type 1 Diabetes
KLRA KAI-4729 Overweight or Obesity
LEXX Arm 4 - Rybelsus medication (semaglutide Type2diabetes
LEXX Arm 5- Tirzepatide Type2diabetes
LEXX Arm 2 - DehydraTECH-semaglutide alone Type2diabetes
LEXX Arm 1 - DehydraTECH-CBD alone Type2diabetes
LEXX Arm 3 - DehydraTECH-CBD in combination w Type2diabetes
LGND LGD-6972 Solution Type 2 Diabetes Mellitus (T2DM)
LGND LGD-6972 Capsules Type 2 Diabetes Mellitus (T2DM)
LGND LGD-6972 Type 2 Diabetes Mellitus
LLY LY4057996 IV Diabetes Mellitus, Type 1
LLY Degludec IV Diabetes Mellitus, Type 1
LLY Pre-study basal insulin SC Diabetes Mellitus, Type 1
LLY Degludec SC Diabetes Mellitus, Type 1

Track obesity and metabolic disease catalysts before they hit

BioRadar scores every upcoming FDA decision with an AI Probability of Approval, tracks cash runway and dilution risk, and sends free email alerts. Build a obesity and metabolic disease watchlist in minutes.

Start free →
Data: ClinicalTrials.gov, SEC & FDA filings • Informational only, not investment advice. • All biotech stocks A–Z →

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.

⚠️ This data is for informational purposes only, not investment advice. Always do your own research.